Answer
Migraleve is contraindicated during breastfeeding because codeine may enter breast milk and cause infant respiratory depression, while CYP2D6 ultra-rapid metabolisers may produce higher milk morphine levels that can very rarely cause fatal opioid toxicity in the infant.